Sort
78,016 grants matching “breast cancer”
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
$467,500Neil Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2020 · HL
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
$467,500Neil Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · HL
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
$467,500Neil Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · HL
Chemotherapy plus vaccine for metastatic breast cancer
$467,494Johns Hopkins University · R01 · FY2002 · CA
Predictors of Mammary Gland Development & Breast Fibroglandular Volume at puberty
$467,472Karin B Michels · Brigham And Women'S Hospital · R01 · FY2013 · CA
Estrogen Receptor and NFkB Crosstalk in Breast Cancer
$467,442Jonna Frasor · University Of Illinois At Chicago · R01 · FY2023 · CA
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
$467,441Michael J Petris · University Of Missouri-Columbia · R01 · FY2021 · CA
Tumor Detection and Classification using QUS Technology's Structure Function
$467,423William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Messaging Strategies to Reduce Breast Cancer Over-Screening in Older Women
$467,407Nancy Schoenborn · Johns Hopkins University · R01 · FY2023 · AG
Developing Methods for Precise, Safe and Target-location Specific Histotripsy of Liver Tumors
$467,401Timothy J Ziemlewicz · University Of Wisconsin-Madison · R01 · FY2022 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$467,360Paul Mathew · Tufts Medical Center · R01 · FY2022 · CA
BRCA 1 and 2 and Breast Cancer Development
$467,354David Morse Livingston · Whitehead Institute For Biomedical Res · P01 · FY2011 · CA
Estrogen Receptor and NFkB Crosstalk in Breast Cancer
$467,341Jonna Frasor · University Of Illinois At Chicago · R01 · FY2019 · CA
Prognosis in BRCA1 Associated Breast Cancer
$467,257Pamela J Goodwin · Sinai Health System · R01 · FY2006 · CA
IMPROVING BREAST CANCER VACCINE THERAPY VEIA NORMALIZATION OF TUMOR VASCULATURE AND MICROENVIRONMENT
$467,256The General Hospital Corporation · · FY2011 · Department of Defense
PheWAS and GWAS of Telomere Length to Understand Human Disease
$467,221Scott Joseph Hebbring · Marshfield Clinic Research Foundation · R01 · FY2021 · GM
MR Microwave Absorption and Tomography Imaging
$467,198Keith D. Paulsen · Dartmouth College · R33 · FY2008 · CA
Exosome secretion in breast cancer progression
$467,195Alissa M Weaver · Vanderbilt University · R01 · FY2016 · CA
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
$467,188Anna Karolina Palucka · Jackson Laboratory · R01 · FY2015 · CA
Trial of strategies to communicate genetic information to different ethnic and racial subpopulations
$467,173Vyjeyanthi S Periyakoil · Stanford University · U54 · FY2020 · MD
Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues
$467,172Mark A Anastasio · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
$467,134Michael T Lewis · University Of Utah · U54 · FY2020 · CA
Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance
$467,118Michael T Lewis · University Of Utah · U54 · FY2021 · CA
Role of breast cancer secreted miRNA in brain metastasis
$467,050Shizhen Emily Wang · University Of California, San Diego · R01 · FY2025 · CA
Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection
$467,030Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA